Clinical trials data
Psychomotor Vigilance Task in sleep trials: 237 registered studies
Every registered sleep and sleep disorders study on ClinicalTrials.gov that names the Psychomotor Vigilance Task in an outcome measure: how often it is a primary outcome, the tests named with it, how large the studies are and when they measure it.
- Registered sleep and sleep disorders studies name it in an outcome measure
- 237
- Name it in a primary outcome, 38%
- 89 of 237
Tests named in the same studies
- 1
Symbol Coding35 studies, 14 as a primary outcome
- 2
N-Back Task27 studies, 15 as a primary outcome
- 3
Stroop Color-Word Test15 studies, 5 as a primary outcome
- 4
Digit Span Test13 studies, 4 as a primary outcome
- 5
Go/No-Go Task12 studies, 3 as a primary outcome
- 6
Trail Making Test11 studies, 4 as a primary outcome
- 7
Verbal Learning11 studies, 4 as a primary outcome
- 8
Balloon Risk10 studies, 5 as a primary outcome
- 9
Verbal Fluency9 studies, 2 as a primary outcome
- 10
Paced Visual Serial Addition Test7 studies, 5 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
Studies by start year
A test as a primary outcomeOnly in secondary or other outcomes
Show as a table
| Start year | Studies | A test as a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 2 | 0 |
| 2004 | 0 | 0 |
| 2005 | 2 | 2 |
| 2006 | 4 | 2 |
| 2007 | 3 | 0 |
| 2008 | 4 | 1 |
| 2009 | 2 | 1 |
| 2010 | 8 | 5 |
| 2011 | 4 | 2 |
| 2012 | 3 | 2 |
| 2013 | 6 | 2 |
| 2014 | 7 | 4 |
| 2015 | 7 | 2 |
| 2016 | 13 | 4 |
| 2017 | 11 | 6 |
| 2018 | 16 | 7 |
| 2019 | 16 | 7 |
| 2020 | 13 | 5 |
| 2021 | 17 | 9 |
| 2022 | 19 | 7 |
| 2023 | 17 | 6 |
| 2024 | 17 | 3 |
| 2025 | 17 | 3 |
| 2026 | 28 | 9 |
Phases and study sizes
By phase
- Early phase 13 studies, 2 as a primary outcome
- Phase 18 studies, 4 as a primary outcome
- Phase 1/24 studies, 1 as a primary outcome
- Phase 221 studies, 2 as a primary outcome
- Phase 2/32 studies, 0 as a primary outcome
- Phase 311 studies, 2 as a primary outcome
- Phase 411 studies, 4 as a primary outcome
- Not applicable155 studies, 61 as a primary outcome
- Observational22 studies, 13 as a primary outcome
Participants per study
- Phase 254 median, 26 to 135
- Phase 3150 median, 121 to 172
- Phase 446 median, 36 to 103
- Not applicable57 median, 30 to 97
- Observational100 median, 50 to 144
Show as a table
| Phase | Studies with a size | Median | Middle half |
|---|---|---|---|
| Phase 2 | 21 | 54 | 26 to 135 |
| Phase 3 | 11 | 150 | 121 to 172 |
| Phase 4 | 10 | 46 | 36 to 103 |
| Not applicable | 151 | 57 | 30 to 97 |
| Observational | 21 | 100 | 50 to 144 |
When sleep trials measure it
Latest time point of each outcome
- Within a day41 outcomes, 19 as a primary outcome
- Up to 4 weeks76 outcomes, 30 as a primary outcome
- 1 to 3 months54 outcomes, 15 as a primary outcome
- 3 to 6 months20 outcomes, 2 as a primary outcome
- 6 to 12 months8 outcomes, 3 as a primary outcome
- 1 to 2 years5 outcomes, 4 as a primary outcome
- Over 2 years1 outcomes, 1 as a primary outcome
- No duration given32 outcomes, 15 as a primary outcome
A test as a primary outcomeOnly in secondary or other outcomes
205 of the 237 outcome measures give a duration. A single visit counts as within a day.
Status, results, interventions and countries
Status
- Recruiting54 studies, 12 as a primary outcome
- Not yet recruiting9 studies, 4 as a primary outcome
- Active, not recruiting8 studies, 2 as a primary outcome
- Completed139 studies, 57 as a primary outcome
- Stopped early13 studies, 8 as a primary outcome
- Status unknown14 studies, 6 as a primary outcome
What they test
- Behavioral77 studies, 30 as a primary outcome
- Drug63 studies, 16 as a primary outcome
- Device59 studies, 18 as a primary outcome
- Dietary supplement8 studies, 4 as a primary outcome
- Procedure5 studies, 1 as a primary outcome
- Diagnostic test2 studies, 1 as a primary outcome
- Biological1 studies, 0 as a primary outcome
- Radiation4 studies, 2 as a primary outcome
- Combination product1 studies, 0 as a primary outcome
- Other55 studies, 22 as a primary outcome
- None given7 studies, 5 as a primary outcome
Intervention types as registered. A study can list several; observational studies often list none.
Where their sites are
- United States133 studies, 51 as a primary outcome
- Switzerland20 studies, 3 as a primary outcome
- France17 studies, 5 as a primary outcome
- Singapore10 studies, 8 as a primary outcome
- Canada9 studies, 0 as a primary outcome
- Australia8 studies, 0 as a primary outcome
- Netherlands8 studies, 0 as a primary outcome
- Taiwan7 studies, 1 as a primary outcome
- Italy6 studies, 0 as a primary outcome
- Sweden6 studies, 3 as a primary outcome
- Denmark5 studies, 1 as a primary outcome
- Norway5 studies, 3 as a primary outcome
33 countries in all. A study with sites in several counts in each; 9 list no site.
Reported results
Completed studies with results posted on ClinicalTrials.gov, a results paper the registry links to the study, or both.
Completed sleep and sleep disorders studies that name the Psychomotor Vigilance Task: 83 of 139, 60%
Every completed study with a cognitive outcome: 3,626 of 7,953, 46%
| Results | Completed sleep and sleep disorders studies that name the Psychomotor Vigilance Task | Every completed study |
|---|---|---|
| Results on ClinicalTrials.gov and a paper | 20, 14% | 776, 10% |
| Results on ClinicalTrials.gov only | 16, 12% | 1,139, 14% |
| A results paper only | 47, 34% | 1,711, 22% |
| Neither | 56, 40% | 4,327, 54% |
The 237 studies
237 studies match. 89 name the Psychomotor Vigilance Task in a primary outcome. Median size 60 participants. Median time to the primary outcome: 2 weeks.
Loading 237 studies; the filters turn on when they arrive.
2026 is partly planned starts.
Show as a table
| Start year | Studies | As a primary outcome |
|---|---|---|
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 2 | 0 |
| 2004 | 0 | 0 |
| 2005 | 2 | 2 |
| 2006 | 4 | 2 |
| 2007 | 3 | 0 |
| 2008 | 4 | 1 |
| 2009 | 2 | 1 |
| 2010 | 8 | 5 |
| 2011 | 4 | 2 |
| 2012 | 3 | 2 |
| 2013 | 6 | 2 |
| 2014 | 7 | 4 |
| 2015 | 7 | 2 |
| 2016 | 13 | 4 |
| 2017 | 11 | 6 |
| 2018 | 16 | 7 |
| 2019 | 16 | 7 |
| 2020 | 13 | 5 |
| 2021 | 17 | 9 |
| 2022 | 19 | 7 |
| 2023 | 17 | 6 |
| 2024 | 17 | 3 |
| 2025 | 17 | 3 |
| 2026 | 28 | 9 |
Library tests named most
Largest condition groups
Phases
Participants
Lead sponsor: industry 29, NIH 1, other 207. Interventional 215, observational 22.
As a primary outcomeSecondary or other outcomeThe Psychomotor Vigilance Task
The studies, newest registration first
Each number opens the study's record on ClinicalTrials.gov.
| Study | Start | Phase | Conditions | Participants | Lead sponsor | Status | Library tests named, with the latest time point |
|---|---|---|---|---|---|---|---|
| NCT07897474 | Start2026 | PhaseObservational | ConditionsSleep and sleep disorders | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07889466 | Start2025 | PhaseNot applicable | ConditionsSleep and sleep disorders, Pain and fatigue | Participants203 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07848659 | Start2026 | PhasePhase 1 | ConditionsSleep and sleep disorders | Participants12 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07846865 | Start2026 | PhasePhase 2/3 | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants256 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07830056 | Start2025 | PhasePhase 4 | ConditionsSleep and sleep disorders | Participants33 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07766343 | Start2026 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants760 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07744581 | Start2026 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants25 | Lead sponsorOther | StatusActive, not recruiting | Library tests named
|
| NCT07695246 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise, Sleep and sleep disorders | Participants183 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07678918 | Start2026 | PhaseObservational | ConditionsSleep and sleep disorders | Participants86 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07639229 | Start2025 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants64 | Lead sponsorOther | StatusCompleted | Library tests named
|
| NCT07613710 | Start2025 | PhasePhase 1 | ConditionsSleep and sleep disorders | Participants104 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07608614 | Start2025 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants16 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07584538 | Start2026 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants75 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07545421 | Start2026 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants100 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07542756 | Start2026 | PhasePhase 4 | ConditionsSleep and sleep disorders | Participants1,200 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07540897 | Start2026 | PhasePhase 3 | ConditionsSleep and sleep disorders | Participants150 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07502443 | Start2026 | PhasePhase 3 | ConditionsSleep and sleep disorders | Participants176 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07495592 | Start2026 | PhaseNot applicable | ConditionsSleep and sleep disorders, Pain and fatigue | Participants32 | Lead sponsorIndustry | StatusCompleted | Library tests named
|
| NCT07494084 | Start2026 | PhasePhase 4 | ConditionsObesity and diabetes, Sleep and sleep disorders | Participants48 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07477184 | Start2026 | PhaseNot applicable | ConditionsAging, frailty and exercise, Sleep and sleep disorders, Anxiety, PTSD and OCD | Participants50 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07455383 | Start2026 | PhasePhase 3 | ConditionsSleep and sleep disorders, Pain and fatigue | Participants150 | Lead sponsorIndustry | StatusRecruiting | Library tests named
|
| NCT07409883 | Start2026 | PhaseObservational | ConditionsSleep and sleep disorders | Participants28 | Lead sponsorOther | StatusNot yet recruiting | Library tests named
|
| NCT07363720 | Start2026 | PhasePhase 3 | ConditionsSleep and sleep disorders | Participants98 | Lead sponsorIndustry | StatusActive, not recruiting | Library tests named
|
| NCT07355842 | Start2026 | PhaseNot applicable | ConditionsParkinson's disease, Sleep and sleep disorders | Participants80 | Lead sponsorOther | StatusRecruiting | Library tests named
|
| NCT07337915 | Start2026 | PhaseNot applicable | ConditionsSleep and sleep disorders | Participants72 | Lead sponsorOther | StatusRecruiting | Library tests named
|
Questions, answered from the data
How many sleep trials use the Psychomotor Vigilance Task?
237 registered sleep and sleep disorders studies on ClinicalTrials.gov name it in an outcome measure, 89 of them in a primary outcome: 32% of the condition's 749 studies with a cognitive outcome, against 2% of all of them. It is the test sleep trials name most.
Which tests do sleep trials use with the Psychomotor Vigilance Task?
Symbol Coding (35 studies), the N-Back Task (27 studies) and the Stroop Color-Word Test (15 studies).
How many participants do phase 2 sleep trials that use the Psychomotor Vigilance Task enroll?
Half of the phase 2 studies that name it enroll 54 participants or fewer, and the middle half enroll 26 to 135. 21 of them give a size.
When do sleep trials measure the Psychomotor Vigilance Task?
Half of the primary outcomes that name the Psychomotor Vigilance Task are measured within 2 weeks of the start, and the middle half from the first day to 6 weeks. 74 primary outcomes give a duration.
How many completed sleep trials that use the Psychomotor Vigilance Task have reported results?
83 of the 139 completed studies that name it, 60%, have reported results: 36 posted them on ClinicalTrials.gov, 67 have a results paper linked to the registry record, and 20 did both. The other 56 show neither. Of all completed studies with a cognitive outcome, 46% have reported results.
How the studies are counted
For each test family, the census runs ClinicalTrials.gov's own outcome search for the family's names and reads every study first posted by the day the family was counted. These studies were read on 10 November 2026. A study counts once on a page, however many tests it names. Counts for a test cover every version of the task under any of its names, so a page can count studies that used a commercial version.
The census adds two things to each record and changes nothing in it: which outcome list names the test (primary, then secondary, then other), and the condition groups, matched on the study's condition names and MeSH terms. A study can fall in several groups; one whose only condition is cognitive impairment or decline falls in “Cognitive impairment and decline”. Studies that name only instruments outside the library count in every total and share but are not listed.
A second read on 10 November 2026 added each study's overall status, whether results are posted, its intervention types, the countries of its sites and the time frame of the outcome that names each test. A time frame counts by the latest time point it names: “Baseline, 12 and 24 weeks” is 24 weeks, a single visit is within a day, and one that names no duration, such as “end of treatment”, is left out of the timings.
A third read on 10 November 2026 added the papers the registry links to each study: those its sponsor lists as reporting results, and those PubMed links to it through the study's NCT number. A study has a results paper when one of them came out in or after the month of its primary completion and PubMed does not class it as a protocol, review or comment. A paper that never gives the NCT number is not linked, so some studies counted as reporting neither did publish.
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine, which does not endorse these pages. Every study line is in the data release 2.1.0, and the explorer's own file is clinical-trials-studies.json.
Run the Psychomotor Vigilance Task in your trial
Choose tests with a record in registered trials, and run them in a browser at every site, on the same version each visit.